Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rocio Sedano

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Current Opinion in Pharmacology|August 1, 2025
Recent innovations in clinical trial design for inflammatory bowel diseaseRocio Sedano, Christopher Ma, Vipul Jairath
ACG Case Reports Journal|November 3, 2025
Gastric and Duodenal Mucosal Healing With Risankizumab in Upper Gastrointestinal Crohn's DiseaseMark Chatto, Rocio Sedano, Vipul Jairath
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 9, 2020
Intravenous Ustekinumab Reinduction Is Effective in Prior Biologic Failure Crohn's Disease Patients Already on Every-4-Week DosingRocio Sedano, Leonardo Guizzetti, Cassandra McDonald, et al.
Gastroenterology & Hepatology|May 4, 2022
Janus Kinase Inhibitors for the Management of Patients With Inflammatory Bowel DiseaseRocio Sedano, Christopher Ma, Vipul Jairath, et al.
United European Gastroenterology Journal|November 14, 2024
Heterogeneity of definition of upper gastrointestinal tract in different guidelines of Crohn's disease: A scoping reviewYuhong Yuan, Rocio Sedano, Virginia Solitano, et al.
Best Practice & Research. Clinical Gastroenterology|August 6, 2025
Reaching the therapeutic ceiling in IBD: Can Advanced Combination Treatment (ACT) offer a solution?Virginia Solitano, Jurij Hanžel, Maria Manuela Estevinho, et al.
The American Journal of Gastroenterology|December 1, 2022
Immunotherapy for Cancer: Common Gastrointestinal, Liver, and Pancreatic Side Effects and Their ManagementRocio Sedano, Daniel Cabrera, Andrea Jiménez, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|October 26, 2020
Clinical Trials of IL-12/IL-23 Inhibitors in Inflammatory Bowel DiseaseAhmed Almradi, Jurij Hanzel, Rocio Sedano, et al.
Inflammatory Bowel Diseases|July 19, 2022
Clinical, Endoscopic, and Radiological Effectiveness of Ustekinumab in Bio-naïve Versus Bio-experienced Patients With Crohn's Disease: Real-world Experience From a Large Canadian CenterRocio Sedano, Leonardo Guizzetti, Cassandra McDonald, et al.
Therapeutic Advances in Gastroenterology|February 25, 2025
Artificial intelligence to revolutionize IBD clinical trials: a comprehensive reviewRocio Sedano, Virginia Solitano, Sudheer K Vuyyuru, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Current Opinion in Pharmacology|August 1, 2025
Recent innovations in clinical trial design for inflammatory bowel diseaseRocio Sedano, Christopher Ma, Vipul Jairath
ACG Case Reports Journal|November 3, 2025
Gastric and Duodenal Mucosal Healing With Risankizumab in Upper Gastrointestinal Crohn's DiseaseMark Chatto, Rocio Sedano, Vipul Jairath
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 9, 2020
Intravenous Ustekinumab Reinduction Is Effective in Prior Biologic Failure Crohn's Disease Patients Already on Every-4-Week DosingRocio Sedano, Leonardo Guizzetti, Cassandra McDonald, et al.
Gastroenterology & Hepatology|May 4, 2022
Janus Kinase Inhibitors for the Management of Patients With Inflammatory Bowel DiseaseRocio Sedano, Christopher Ma, Vipul Jairath, et al.
United European Gastroenterology Journal|November 14, 2024
Heterogeneity of definition of upper gastrointestinal tract in different guidelines of Crohn's disease: A scoping reviewYuhong Yuan, Rocio Sedano, Virginia Solitano, et al.
Best Practice & Research. Clinical Gastroenterology|August 6, 2025
Reaching the therapeutic ceiling in IBD: Can Advanced Combination Treatment (ACT) offer a solution?Virginia Solitano, Jurij Hanžel, Maria Manuela Estevinho, et al.
The American Journal of Gastroenterology|December 1, 2022
Immunotherapy for Cancer: Common Gastrointestinal, Liver, and Pancreatic Side Effects and Their ManagementRocio Sedano, Daniel Cabrera, Andrea Jiménez, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|October 26, 2020
Clinical Trials of IL-12/IL-23 Inhibitors in Inflammatory Bowel DiseaseAhmed Almradi, Jurij Hanzel, Rocio Sedano, et al.
Inflammatory Bowel Diseases|July 19, 2022
Clinical, Endoscopic, and Radiological Effectiveness of Ustekinumab in Bio-naïve Versus Bio-experienced Patients With Crohn's Disease: Real-world Experience From a Large Canadian CenterRocio Sedano, Leonardo Guizzetti, Cassandra McDonald, et al.
Therapeutic Advances in Gastroenterology|February 25, 2025
Artificial intelligence to revolutionize IBD clinical trials: a comprehensive reviewRocio Sedano, Virginia Solitano, Sudheer K Vuyyuru, et al.
Pageof 4